ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

BLCO Bausch plus Lomb Corporation

13.26
-0.60 (-4.33%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Bausch plus Lomb Corporation BLCO NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.60 -4.33% 13.26 09:00:00
개장가 저가 고가 종가 전일 종가
14.04 13.53 14.35 13.60 13.86
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202419:58BWBausch + Lomb Announces First-Quarter 2024 Results
29/04/202420:00BWBausch + Lomb Announces Presentation of New Data at the..
25/04/202421:30BWBausch + Lomb Announces Statistically Significant Results..
18/04/202420:00BWBausch + Lomb Reports More Than 84 Million Units of Contact..
16/04/202401:00BWBausch + Lomb Will Release First-Quarter 2024 Financial..
27/03/202420:00BWBausch + Lomb Will Present New Scientific Data and Analyses..
05/03/202407:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202407:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/02/202422:12EDGAR2Form 8-K - Current report
28/02/202422:00BWBausch + Lomb Announces Appointment of Karen L. Ling to..
21/02/202421:00EDGAR2Form 8-K - Current report
21/02/202421:00GLOBEEmergent BioSolutions Appoints Industry Leader Joseph C...
21/02/202420:58BWBausch + Lomb Announces Fourth-Quarter and Full-Year 2023..
06/02/202402:00BWBausch + Lomb Will Release Fourth-Quarter and Full-Year 2023..
08/01/202420:59BWBausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser..
04/01/202406:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/01/202423:00BWBausch + Lomb to Participate in the 42nd Annual J.P. Morgan..
15/11/202320:59BWBausch + Lomb Reports More Than 76 Million Units of Contact..
14/11/202306:47EDGAR2Form 8-K/A - Current report: [Amend]
08/11/202307:00EDGAR2Form 8-K/A - Current report: [Amend]
02/11/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202320:02EDGAR2Form 8-K - Current report
01/11/202319:58BWBausch + Lomb Announces Third-Quarter 2023 Results and..
26/10/202319:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
17/10/202301:00BWBausch + Lomb Will Release Third-Quarter 2023 Financial..
04/10/202319:59BWBausch + Lomb Will Present New Scientific Data and Analyses..
04/10/202306:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/09/202305:24EDGAR2Form 8-K - Current report
29/09/202323:00BWBausch + Lomb Completes Acquisition of XIIDRA®
26/09/202319:59BWBausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the..
20/09/202319:59BWBausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling..
15/09/202306:26EDGAR2Form 8-K - Current report
15/09/202306:25BWBausch + Lomb Announces Pricing of Senior Secured Notes..
12/09/202319:59BWBausch + Lomb Launches MIEBO™ (Perfluorohexyloctane..
11/09/202320:22EDGAR2Form 8-K - Current report
11/09/202320:07BWBausch + Lomb Announces Launch of Proposed Financing for..
07/09/202306:58BWBausch + Lomb Announces Disclosure of Historical and Pro..
07/09/202306:28EDGAR2Form 8-K - Current report
06/09/202319:59BWBausch + Lomb Will Present New Scientific Data on its..
30/08/202306:05EDGAR2Form 8-K/A - Current report: [Amend]
29/08/202320:00BWBausch + Lomb Will Participate at the 2023 Wells Fargo..
24/08/202320:00BWBausch + Lomb Announces Expiration of Hart-Scott-Rodino..
03/08/202306:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/08/202306:09EDGAR2Form S-3ASR - Automatic shelf registration statement of..
03/08/202305:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

최근 히스토리

Delayed Upgrade Clock